Business Combination - Additional Information (Details)		3 Months Ended				6 Months Ended
	Mar. 25, 2022 USD ($) Market	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($) Market	Jun. 30, 2021 USD ($)
Business Acquisition [Line Items]
Goodwill		$ 11,897,407				$ 11,897,407
Intangible assets, Estimated period of benefit						10 years
Product sales		$ 8,819,786				$ 8,819,786
Type of Revenue [Extensible List]		us-gaap:ProductMember				us-gaap:ProductMember
Net loss		$ (41,438,516)	$ (39,632,311)	$ (32,284,209)	$ (29,259,970)	$ (81,070,827)	$ (61,544,179)
Selling, General and Administrative Expenses
Business Acquisition [Line Items]
Business combination, transaction costs						$ 500,000
Hercules Capital Inc | Term Loan
Business Acquisition [Line Items]
Line of credit	$ 300,000,000
Jazz Pharmaceuticals Plc
Business Acquisition [Line Items]
Business combination purchase price allocated to goodwill deductible in number of years						15 years
Sunosi
Business Acquisition [Line Items]
Number of Asian markets | Market						12
Revenue milestones	165,000,000					$ 165,000,000
Development milestones	1,000,000					1,000,000
Inventory step-up fair value		1,100,000				1,100,000
Goodwill		11,900,000				11,900,000
Product sales		$ 8,800,000				$ 8,800,000
Type of Revenue [Extensible List]		us-gaap:ProductMember				us-gaap:ProductMember
Net loss		$ (4,600,000)				$ (4,600,000)
Sunosi | Jazz Pharmaceuticals Plc
Business Acquisition [Line Items]
Upfront payment	$ 53,000,000
Number of Asian markets | Market	12
Cash and contingent consideration						89,140,407
Goodwill		$ 11,897,407				$ 11,897,407
Intangible assets, Estimated period of benefit						10 years
Sunosi | Jazz Pharmaceuticals Plc | Discount rate
Business Acquisition [Line Items]
Percentage of discount rate intangible asset measurement input		43.50%				43.50%